Stockreport

Lexeo Therapeutics to Participate in Upcoming Investor Conferences in February

Lexeo Therapeutics, Inc.  (LXEO) 
PDF NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated to pioneering novel treatments [Read more]